The CRO of Morgan Stanley (NYSE: MS) is Selling Shares

Yesterday, the CRO of Morgan Stanley (MSResearch Report), Keishi Hotsuki, sold shares of MS for $1.29M.

Following Keishi Hotsuki’s last MS Sell transaction on May 09, 2014, the stock climbed by 22.6%. This is Hotsuki’s first transaction since reporting a Sell transaction on BSL back in August 2016

See today’s analyst top recommended stocks >>

Based on Morgan Stanley’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $13.2 billion and quarterly net profit of $2.17 billion. In comparison, last year the company earned revenue of $12.52 billion and had a net profit of $2.11 billion. The company has a one-year high of $49.98 and a one-year low of $36.74. MS’s market cap is $80.09B and the company has a P/E ratio of 10.47.

The insider sentiment on Morgan Stanley has been neutral according to 65 insider trades in the past three months. This sentiment is slightly lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Morgan Stanley provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following business segments: Institutional Securities, Wealth Management, and Investment Management.